| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $58.6M | — | -1.6% |
| Cost of Revenue | $29.0M | — | +2.2% |
| Gross Profit | $29.5M | — | -5.1% |
| R&D Expense | $43.8M | — | -4.4% |
| SG&A Expense | $22.9M | — | -11.2% |
| Operating Income | -$48.8M | — | +4.1% |
| Pre-tax Income | -$59.6M | — | +0.3% |
| Income Tax | $408K | — | +1357.1% |
| Net Income | -$60.0M | — | -0.4% |
| EPS (Basic) | -$0.81 | — | +1.2% |
| EPS (Diluted) | -$0.81 | — | +1.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $260.3M | +12.9% | -20.2% |
| Short-term Investments | $138.7M | -15.9% | -20.4% |
| Accounts Receivable | $27.3M | -67.2% | +33.9% |
| Current Assets | $464.0M | -10.7% | -18.7% |
| Total Assets | $634.2M | -12.7% | -14.6% |
| Current Liabilities | $169.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.8M | — | -110.3% |
| Capital Expenditures | $2.5M | — | +320.6% |
| Investing Cash Flow | $44.6M | — | +45.6% |
| Financing Cash Flow | $569K | — | +39.1% |
| Free Cash Flow | -$17.3M | — | -112.1% |
| +2.5% |
| Total Liabilities | $320.6M | -11.5% | -13.2% |
| Stockholders' Equity | $313.5M | -13.9% | -16.1% |